Notice Filed with SOS |
12/14/2015 |
Rule |
ProposedRuleAttach2015-00836.pdf |
Additional Information |
AddInfoAttach2015-00836.pdf |
Statutory Authority |
Sections 12-29.5-102, 12-29.5-102.5, 12-37-105.5, 12-37.3-105, 12-42.5-101, 12-42.5-105, 12-42.5-106(2) and (3), 12-42.5-118(6)(b), 12-42.5-120, 12-42.5-130(2), 12-42.5-133, and 24-4-103, C.R.S. |
Description of Subjects/Issues |
Hearing to repeal, modify, amend, revise or adopt portions of existing rules. |
Purpose/Objective of Rule |
The purpose of the amendments and
3.00.21 - to make the rule consistent
15-1029; (2) Rule 3.00.27 - to specify
outlet reconstitution of a drug may be
clarify the training requirements for p
administer vaccines and immunizatio
whom an in-state prescription drug ou
prescription drugs, to include naturop
and acupuncturists; (5) Rules 21.11.2
compounded drug recall requirement
conditions under which allergen extra
21.20.20 - to clarify the requirements
12-hour or less beyond-use dating; a
environmental and quality control req
Isolators and Containment Isolators. |
Submitted in response to issues raised by COLS/OLLS? |
No
|
Is this rule adopted in response to recent legislation? |
Yes
|
Recent legislation bill number |
HB- 15-1029 Rule 3.00.21 only
|
Hearing Date |
01/21/2016 |
Hearing Time |
09:00 AM |
Hearing Location |
1560 Broadway, Suite 110D, Denver, CO 80202 |
Contact Name |
Andrea Faley |
Contact Title |
Program Director |
Contact Telephone |
303-894-7754 |
Contact email |
andreae.faley@state.co.us |